Abstract:Introduction: Increasing long noncoding RNAs (lncRNAs) have been reported to play key role in the development and progression in many types of malignancies. ZNFX1 antisense RNA1(ZFAS1) has been reported to be aberrant expression and suggested as a tumor suppressor or oncogene in many cancers. However, the biological role and underlying molecular mechanism of ZFAS1, especially the miRNA sponge role of which in colon cancer remain largely unknown. Methods: Quantitative PCR was employed to evaluate the level of ZFAS1, miR-150-5p and VEGF-A mRNA expression in colon cancer tissues and cell lines. CCK-8, colony formation, wound-healing, transwell chamber and tube formation assays were used to detect the effects of ZFAS1 on colon cancer cell proliferation, migration, invasion and angiogenesis, respectively. Luciferase reporter assays were applied to confirm the miR-150-5p target genes, and RIP assay was used to determine whether ZFAS1 binds to miR-150-5p in an AGO2-dependent manner. In vivo tumor growth and metastasis were conducted in nude mice, and in vivo tumor angiogenesis was conducted using chicken chorioallantoic membrane model. The markers of metastasis and angiogenesis- VEGFA, CD31, MMP-9, E-cadherin, N-cadherin and Vimentin, VEGFR2, Akt, mTOR and phosphorylation of VEGFR2(p-VEGFR2), phosphorylation of Akt (p-Akt), phosphorylation of mTOR(p-mTOR) were detected by using immunohistochemistry and western blot analysis. Results: In our study, by using TCGA database, we identified a group of differentially expressed lncRNAs in human colon cancer, including ZFAS1, which mainly located in the cytoplasm with RNA-FISH. We found that ZFAS1 expression was higher in colon cancer tissues, where it was associated with TNM stage, pTstage, distant metastasis and poor overall survival. Moreover, ZFAS1 and VEGF-A are target genes of miR-150-5p, while ZFAS1 binds to miR-150-5p in an AGO2-dependent manner. Additionally, ZFAS1 knockdown significantly suppressed colon cancer cell proliferation, migration, invasion, EMT and angiogenesis in vitro, and also inhibited tumor growth, metastasis and angiogenesis in vivo. While antagomiR-150-5p or VEGF-A could reverse ZFAS1 knockdown- induced suppressing of proliferation, metastasis and angiogenesis both in vitro and in vivo. Lastly, ZFAS1 knockdown could markedly reduce the expression of VEGF-A, p-VEGFR2, p-Akt and p-mTOR, VEGFR2 inhibitor Ki8751 could obviously decrease the expression of p-VEGFR2, p-Akt and p-mTOR and inhibited colon cancer cell proliferation, metastasis and angiogenesis. Based on above data, we could conclude that ZFAS1 promoted colon cancer growth, metastasis and angiogenesis via activating VEGFA/VEGFR2 and downstream Akt/mTOR signaling pathway. Conclusion: ZFAS1 promoted tumor progression by upregulating VEGF-A via competitively binding to miR-150-5p, which acts as a tumor suppressor by targeting VEGF-A in colon cancer. Furthermore, we verified that ZFAS1 promoted colon cancer cell proliferation, metastasis, angiogenesis and EMT process via activated VEGFA/VEGFR2/Akt/mTOR signaling pathway in colon cancer.

VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice

Silencing Of Atp6v1c1 Prevents Breast Cancer Growth And Bone Metastasis

VIRMA Contributes to Non-Small Cell Lung Cancer Progression Via N6-methyladenosine-dependent DAPK3 Post-Transcriptional Modification.

The VIM-AS1/miR-655/ZEB1 axis modulates bladder cancer cell metastasis by regulating epithelial–mesenchymal transition

Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/-catenin signaling pathway

Targeting the ZMIZ1-Notch1 signaling axis for the treatment of tongue squamous cell carcinoma

RNA-binding Protein ZC3H18 Enhances Cell Proliferation and Metastasis in Lung Adenocarcinoma

Increased dosage of wild-type KRAS protein drives -mutant lung tumorigenesis and drug resistance

PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma

A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer

ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer

The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL

Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10

LncRNA-ZFAS1 Contributes to Colon Cancer Progression Through the Mir-150-5p/vegfa Axis

VEGF-B Promotes Cancer Metastasis Through a VEGF-A–independent Mechanism and Serves As a Marker of Poor Prognosis for Cancer Patients

Inactivation Of Von Hippel-Lindau Increases Ovarian Cancer Cell Aggressiveness Through The Hif1 Alpha/Mir-210/Vmp1 Signaling Pathway

Breast Cancer Cells-Derived Von Willebrand Factor Promotes VEGF-A-related Angiogenesis Through PI3K/Akt-miR-205-5p Signaling Pathway

Overexpression Of Rhov Promotes The Progression And Egfr-Tki Resistance Of Lung Adenocarcinoma

Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion

Overexpression of Raf-1 Kinase Inhibitor Protein Inhibits Cell Invasion and Migration in Lung Cancer Cells Through Suppressing Epithelial-Mesenchymal Transition.